NevadaLIFE  Nevada Life Issues Forum and Education
Educating Nevadans on Life Issues...

 



 
Quick Links

Radio Show
Crisis Pregnancy Centers
Abortion Info Sites

 

 

   

Opinion- Ban Prevents Tampering With Human Life

Don Nelson, President
Nevada LIFE

Reno Gazette Journal

September 28, 2004

SPECIAL TO THE RENO GAZETTE-JOURNAL
9/27/2004 10:21 pm 

The ban on federal funding of embryonic stem cell research must continue as a minimal safeguard for ethical science in the face of the powerful biotech industry.

Embryonic stem cell research (ESCR) is one type of stem cell research that procures stem cells by destroying human embryos. The current policy excludes federal taxpayer funding of embryonic stem cell lines created after August 2001. It allows funding for and has funded research on embryonic stem cell lines existing before August 2001. It does not exclude private funding, though Nevada LIFE and others oppose it.

The policy is important because ESCR kills embryonic human beings to obtain these kinds of stem cells for research. If allowed, this research would loudly proclaim that humanness is not enough to protect human life. There can be and will be classes of human beings that can be exploited — even intentionally created and harvested — for the benefit of others.

Right-to-life opponents — though not the only opponents — object because humans have intrinsic value at any stage by virtue of being human. Human dignity and value are woven into the fabric of our being from the moment of our creation. These are not achieved as if size, location —whether in a womb or a lab dish —level of development or degree of dependency makes us more human. Nor are dignity and value diminished by the means of conception. Ethical research requires that humans not be experimented upon without consent.

Many ESCR supporters evade the moral issues by making the cheap ad-hominem charge that opponents are anti-research. Opponents are not anti-research. They are anti-unethical research and strongly support almost all stem cell research. They object to what ESCR does to embryonic human beings and how it will inevitably target others. Once we cave in to the idea that medical results justify exploitive human research, then we all become potential targets in the name of research and progress.

ESCR researchers say they want a 10- to 14-day window in which it will be legal to kill human embryos for research. Events in New Jersey illustrate that this will not be enough for them. Gov. McGreevey signed a law this year making it legal to create a cloned human embryo, implant it in the womb and allow the newly cloned human to grow until birth. Throughout this pregnancy period researchers can grow and kill the fetus and use “cadaveric” tissue for research and transplantation purposes without penalty — so long as the fetus is not born alive. Prop. 71 in California will do the same. Welcome to biotech ethics.

ESCR proponents, with the polish of faith healers, promise amazing cures. John Kerry says that if we’ll just elect him, cures are at our fingertips. The truth is that ESCR has been a bust. Other stem cell research using a person’s own stem cells or stem cells from umbilical cord blood or placental tissues are achieving positive results. Treatments using a person’s own stem cells have treated over 80 different diseases. Embryonic stem cells have treated no one.

Opponents of the current policy say it sacrifices science for ideology. This is an instance of the accuser being guilty of the charge. Fixation with ESCR has caused real harm to American sufferers by leaving them to go to other countries for help where other stem cell research is achieving promising results.

The current policy has been an important first step. But more needs to be done to prevent further exploration and tampering with human life.

Don Nelson is the president of Nevada LIFE (Life Issues Forum and Education).

 

 

 

 

 

Copyright © 2002 NevadaLIFE ~ A not-for-profit organization
PO Box 50786 Sparks, NV 89435-0786  contact@nevadalife.org  (775) 530-0029  626-1024 (fax)